SCHEDULE 13D/A
Beneficial Ownership Report
SAB Biotherapeutics, Inc. Filed Acc 0001346824-26-000079
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13D_X02/primary_doc.xml…